Xiufeng Liu Selected Research

Melanoma (Melanoma, Malignant)

10/2021	Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment.
1/2020	Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial.
1/2020	Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial.
1/2017	Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism.
1/2015	Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma.
2/2012	Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiufeng Liu Research Topics

Disease

18	Neoplasms (Cancer) 12/2023 - 02/2012
8	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2019
6	Melanoma (Melanoma, Malignant) 10/2021 - 02/2012
4	Infections 01/2024 - 01/2015
4	Wounds and Injuries (Trauma) 02/2018 - 11/2015
3	Inflammation (Inflammations) 01/2023 - 01/2017
3	Disease Progression 01/2023 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2017
3	Carcinoma (Carcinomatosis) 01/2019 - 04/2013
2	Thrombosis (Thrombus) 03/2024 - 03/2024
2	Body Weight (Weight, Body) 01/2023 - 01/2020
2	COVID-19 12/2022 - 10/2021
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020 - 01/2019
2	Experimental Arthritis 12/2018 - 01/2018
2	Hypoxia (Hypoxemia) 01/2015 - 02/2012
1	Babesiosis (Piroplasmosis) 01/2024
1	Insulin Resistance 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Dysbiosis 01/2023
1	Obesity 01/2023
1	Cholangiocarcinoma 01/2023
1	Hyperalgesia 05/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Vomiting 01/2022
1	Pica (Geophagia) 01/2022
1	Nausea 01/2022
1	Anorexia 01/2022
1	Lung Diseases (Lung Disease) 10/2021
1	Cough 10/2021
1	Asthma (Bronchial Asthma) 10/2021
1	Bacterial Infections (Bacterial Infection) 10/2021
1	Infertility (Sterility) 01/2021
1	Myocarditis (Carditis) 04/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Dyskinesias (Dyskinesia) 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Hepatitis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2013
6	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2019
4	LigandsIBA 01/2023 - 02/2012
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2020
3	VNP 20009 (VNP20009)IBA 01/2017 - 02/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 02/2012
2	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2019
2	NivolumabIBA 04/2020 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2019
2	Sunitinib (Sutent)FDA Link 01/2020 - 01/2019
2	toripalimabIBA 01/2020 - 01/2020
2	apatinibIBA 01/2019 - 01/2019
2	DC32IBA 12/2018 - 01/2018
2	artenimol (dihydroartemisinin)IBA 12/2018 - 01/2018
2	CelluloseIBA 02/2018 - 11/2015
2	Messenger RNA (mRNA)IBA 01/2018 - 06/2015
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2017 - 11/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 06/2015
2	Urokinase Plasminogen Activator ReceptorsIBA 10/2014 - 01/2014
1	IntegrinsIBA 03/2024
1	ImmunosorbentsIBA 01/2024
1	EnzymesIBA 01/2024
1	pembrolizumabIBA 03/2023
1	tributyl phosphate (TBP)IBA 01/2023
1	Tight Junction ProteinsIBA 01/2023
1	LipidsIBA 01/2023
1	CytokinesIBA 01/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	KaolinIBA 01/2022
1	AcidsIBA 10/2021
1	Angiotensin-Converting Enzyme 2IBA 10/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	FlagellinIBA 10/2021
1	atezolizumabIBA 06/2021
1	Bevacizumab (Avastin)FDA Link 06/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	ZearalenoneIBA 01/2021
1	donafenibIBA 01/2021
1	camrelizumabIBA 04/2020
1	Gemcitabine FDA Link 04/2020
1	GlucocorticoidsIBA 04/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 02/2019
1	corydalmineIBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 01/2019

Therapy/Procedure

18	Therapeutics 03/2024 - 02/2012
7	Drug Therapy (Chemotherapy) 12/2023 - 03/2014
4	Immunotherapy 12/2023 - 01/2019
1	Blood Transfusion (Blood Transfusions) 01/2024
1	Hospice Care (Care, Bereavement) 12/2022
1	Intraperitoneal Injections 05/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021
1	Traditional Medicine (Folk Remedies) 10/2021
1	Hepatectomy 03/2021
1	Precision Medicine 02/2019